17 Patents
- US125841302026Angiotensinogen (AGT) Irna Compositions and Methods of Use Thereof
Alnylam Pharmaceuticals, Inc.
0 cites - US125775642026Sterol Regulatory Element Binding Protein (SREBP) Chaperone (SCAP) Irna Compositions and Methods of Use Thereof
Alnylam Pharmaceuticals, Inc.
0 cites - US125695112026Patatin-like Phospholipase Domain Containing 3 (PNPLA3) Irna Compositions and Methods of Use Thereof
Alnylam Pharmaceuticals, Inc.
0 cites - US124924012025Angiopoietin-like 3 (ANGPTL3) Irna Compositions and Methods of Use Thereof
Alnylam Pharmaceuticals, Inc.
0 cites - US12359201202517ß-hydroxysteroid Dehydrogenase Type 13 (HSD17B13) Irna Compositions and Methods of Use Thereof
Regeneron Pharmaceuticals, Inc.
0 cites - US123384392025Factor XII (hageman Factor) (F12), Kallikrein B, Plasma (fletcher Factor) 1 (KLKB1), and Kininogen 1 (KNG1) Irna Compositions and Methods of Use Thereof
Alnylam Pharmaceuticals, Inc.
0 cites - US122277442025Compositions and Methods for Inhibiting Expression of Transthyretin
Alnylam Pharmaceuticals, Inc.
0 cites - 0 cites
- US120916662024Xanthine Dehydrogenase (XDH) Irna Compositions and Methods of Use Thereof
Alnylam Pharmaceuticals, Inc.
0 cites - 0 cites
- US120311332024GNAQ Targeted Dsrna Compositions and Methods for Inhibiting Expression
Alnylam Pharmaceuticals, Inc.
0 cites - US119877922024Compositions and Methods for Inhibiting Expression of the LECT2 Gene
ALNYLAM PHARMACEUTICALS, Inc.
0 cites - US118849192024Lipid Formulated Compositions and Methods for Inhibiting Expression of Serum Amyloid a Gene
Alnylam Pharmaceuticals, Inc.
0 cites - US118667012024Complement Component C3 Irna Compositions and Methods of Use Thereof
Alnylam Pharmaceuticals, Inc.
0 cites - US118591852024Glucokinase (GCK) Irna Compositions and Methods of Use Thereof
Alnylam Pharmaceuticals, Inc.
0 cites - US118346612023Angiotensinogen (AGT) Irna Compositions and Methods of Use Thereof
Alnylam Pharmaceuticals, Inc.
0 cites - US116859182023Programmed Cell Death 1 Ligand 1 (PD-L1) Irna Compositions and Methods of Use Thereof
Alnylam Pharmaceuticals, Inc.
0 cites